Cerus | CERS - Cash And Equivalent


Cerus reported $19.96M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Cerus USD 19.96M 4.29M Dec/2025
GRIFOLS EUR 486M 27M Sep/2026
Haemonetics USD 260.71M 37.33M Sep/2026
Neogen USD 172M 13.5M Jun/2026
OraSure Technologies USD 160.58M 16.38M Jun/2026
Plus Therapeutics USD 2.37M 656K Jun/2026
Quidel USD 166.4M 43M Sep/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 133.61M 14.97M Sep/2026
Terumo JPY 280.49B 63.34B Mar/2026
Utah Medical Products USD 84.27M 2.09M Sep/2025